• Translational Acceleration Through Mechanistic Screening:...

  2025-10-23

  This thought-leadership article explores how mechanistically driven high-throughput and high-content screening, anchored by the DiscoveryProbe™ FDA-approved Drug Library, is redefining translational research. Integrating recent experimental breakthroughs, competitive trends, and translational imperatives, we provide strategic guidance for researchers seeking to maximize clinical impact and precision in drug repositioning, target identification, and disease model innovation.

• DiscoveryProbe FDA-approved Drug Library: Transforming Hi...

  2025-10-22

  The DiscoveryProbe™ FDA-approved Drug Library delivers a streamlined, regulatory-validated solution for high-throughput drug repositioning and pharmacological target identification. Its comprehensive, pre-dissolved compound collection empowers researchers to accelerate experimental workflows, troubleshoot efficiently, and unlock novel therapeutic avenues across cancer, neurodegeneration, rare diseases, and metabolic disorders.

• Gastrin I (human): Mechanistic Insights and Next-Gen Appl...

  2025-10-21

  Delve into the mechanistic foundations and advanced research applications of Gastrin I (human), a premier gastric acid secretion regulator. This article uniquely bridges molecular signaling, organoid modeling, and translational pharmacology for gastrointestinal physiology studies.

168 records 12/12 page Previous First page 上5页 1112